List of Studies ( Metabolite:TG 59:2)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST004095 | AN006788 | Hep3B PNPLA3 wild type and PNPLA3(I148M) lipidomics | Cultured cells | Human | Cancer | Amgen | LC-MS |
| ST004049 | AN006694 | Comparison of lipidome from phagosomes containing Pam3csk4-beads vs. uncoupled-beads | Macrophages | Mouse | St Jude Children's Research Hospital | LC-MS | |
| ST003785 | AN006220 | Sex differences in lipid profiles of visceral adipose tissue with obesity and gonadectomy | Tissue | Mouse | Obesity | University of Michigan | LC-MS |
| ST003776 | AN006202 | Investigation of Hepatic Lipid Alterations Following Micro- and Nanoplastic-Ingestion | Liver | Mouse | Environmental exposure | University of Bonn | LC-MS |
| ST003702 | AN006074 | Kupffer cells control neonatal hepatic glucose metabolism via Igf1 signaling - lipidomics analysis of postnatal day 0 murine livers after macropahges depletion using Csf1r conditional KO | Liver | Mouse | University of Bonn | LC-MS | |
| ST003614 | AN005939 | Kupffer cells control neonatal hepatic glucose metabolism via Igf1 signaling - lipidomics analysis of postnatal day 0 murine livers after macropahges depletion | Liver | Mouse | University of Bonn | LC-MS | |
| ST003522 | AN005784 | Untargeted mass spectrometry analysis of neutral lipids in MC38 tumors and visceral adipose tissues of control-diet and high fat diet-fed C57BL/6 mice | Adipose tissue | Mouse | Cancer | Stanford University | LC-MS |
| ST003522 | AN005784 | Untargeted mass spectrometry analysis of neutral lipids in MC38 tumors and visceral adipose tissues of control-diet and high fat diet-fed C57BL/6 mice | Tumor tissue | Mouse | Cancer | Stanford University | LC-MS |
| ST003293 | AN005392 | High Fat Feeding Alters Circulating Triglyceride Profile by Decreasing SCD Activity and Depleting omega-3 Fatty Acids | Blood | Rat | Hyperlipidemia | University of Southern California | LC-MS |
| ST003246 | AN005316 | Effects of mitoregulin loss on cardiac and mitochondrial lipids in aged male mice | Heart | Mouse | Cardiovascular disease | University of Iowa | LC-MS |
| ST003220 | AN005280 | Obesity, sex, and depot drive distinct lipid profiles in murine white adipose tissue | Adipose tissue | Mouse | Obesity | University of Utah | LC-MS |
| ST003157 | AN005179 | Diet modulates the protective effects of dimethyl fumarate mediated by the immunometabolic neutrophil receptor HCA2 - Lipidomics | Blood | Mouse | Multiple sclerosis | University of Luebeck | LC-MS |
| ST003055 | AN005009 | Lipidomics analysis of the liver of THRB deficient (THRBKO) mice under normal chow conditions | Liver | Mouse | University of Luebeck | LC-MS | |
| ST002817 | AN004584 | Investigation of metabolism in hypertrophic cardiomyopathy - Lipidomics | Heart | Mouse | Cardiomyopathy | University of California, San Francisco | LC-MS |
| ST002764 | AN004499 | Identification of pre-diagnostic lipid sets associated with liver cancer risk using untargeted lipidomics and chemical set analysis – a nested case-control study within the ATBC cohort | Blood | Human | Cancer | Icahn School of Medicine at Mount Sinai | LC-MS |
| ST002700 | AN004376 | Metabolomic analysis of maternal mid-gestation plasma and cord blood: lipidomics | Blood | Human | Autism | Columbia University | LC-MS |
| ST002438 | AN003972 | Ozone alters glycosphingolipid metabolism and exacerbates characteristics of asthma in mice | Lung | Mouse | Asthma | University of California, Davis | LC-MS |
| ST002409 | AN003926 | Spatial, temporal, and inter-subject variation of the metabolome along the human upper intestinal tract (MS RP positive data) | Intestine | Human | University of California, Davis | LC-MS | |
| ST002070 | AN003374 | Lipidomic Comparison of 2D and 3D Colon Cancer Cell Culture Models | Cultured cells | Human | Cancer | Ohio State University | LC-MS |
| ST002002 | AN003265 | A case-control study on plasma metabolomics analysis in Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) (Part 3) | Blood | Human | Myalgic encephalomyelitis/chronic fatigue syndrome | Columbia University | LC-MS |
| ST001989 | AN003241 | THEM6-mediated lipid remodelling sustains stress resistance in cancer (Part 3) | LNCaP cells | Human | Cancer | IGMM | LC-MS |
| ST001949 | AN003173 | Plasma Metabolome Normalization in Rheumatoid Arthritis following initiation of Methotrexate and the Identification of Metabolic Biomarkers of Efficacy | Blood | Human | Rheumatoid arthritis | University of Kansas | GC-MS |
| ST001843 | AN002986 | Identification of unique metabolite networks between Latino and Caucasian patients with nonalcoholic fatty liver disease (NAFLD) (part II) | Blood | Human | Fatty liver disease | University of California, Davis | GC-MS |
| ST001843 | AN002986 | Identification of unique metabolite networks between Latino and Caucasian patients with nonalcoholic fatty liver disease (NAFLD) (part II) | Liver | Human | Fatty liver disease | University of California, Davis | GC-MS |
| ST001815 | AN002946 | Metabolic Markers of Methotrexate Response in Juvenile Idiopathic Arthritis | Blood | Human | Arthritis | University of Kansas | GC-MS/LC-MS |
| ST001725 | AN002810 | Lipidomics dataset of Danio rerio optic nerve regeneration model | Eye tissue | Zebrafish | Eye disease | University of Miami | LC-MS |
| ST001292 | AN002149 | Metabolomics of blood plasma and kidney tissue from control (db/m) and diabetic (db/db) mice. | Kidney | Mouse | Diabetes | University of Michigan | LC-MS |
| ST001211 | AN002018 | Metabolomic Markers of Methotrexate Response, In Vitro | Cultured cells | Human | University of Kansas | GC-MS/LC-MS | |
| ST001121 | AN001846 | Identification of urine metabolites in patients with interstitial cystitis using untargeted metabolomics (part I) | Urine | Human | Interstitial cystitis | University of California, Davis | LC-MS |
| ST001063 | AN001739 | Lipidomics analysis for aged mice organs | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001739 | Lipidomics analysis for aged mice organs | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001739 | Lipidomics analysis for aged mice organs | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001739 | Lipidomics analysis for aged mice organs | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST000991 | AN001617 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part IX) | Blood | Human | University of California, Davis | LC-MS | |
| ST000990 | AN001616 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part VIII) | Blood | Human | University of California, Davis | LC-MS | |
| ST000989 | AN001615 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part VII) | Blood | Human | University of California, Davis | LC-MS | |
| ST000988 | AN001614 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part VI) | Blood | Human | University of California, Davis | LC-MS | |
| ST000986 | AN001612 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part IV) | Blood | Human | University of California, Davis | LC-MS | |
| ST000985 | AN001611 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part III) | Blood | Human | University of California, Davis | LC-MS | |
| ST000984 | AN001610 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part II) | Blood | Human | University of California, Davis | LC-MS | |
| ST000983 | AN001609 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (Part I) | Blood | Human | University of California, Davis | LC-MS | |
| ST000915 | AN001488 | Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Liver | Liver | Human | Fatty liver disease | LIPID MAPS | GC-MS/LC-MS |
| ST000780 | AN001235 | High fat diet and sciatic nerves functions | Blood | Mouse | Neuropathy | University of Michigan | LC-MS |
| ST000775 | AN001225 | Michigan Biomarkers for Refractory Depression (Bluebird) metabolomics pilot study | Blood | Human | Depression | University of Michigan | LC-MS |
| ST000669 | AN001025 | Characterization of Retinal Exudates in Coats Disease - lipid profile | Eye tissue | Human | Eye disease | University of Michigan | LC-MS |
| ST000666 | AN001019 | Rat Rotator Cuff Lipidomics | Muscle | Rat | University of Michigan | LC-MS | |
| ST000665 | AN001017 | Nonalcoholic fatty liver disease (NAFLD) Studies | Cultured cells | Human | Fatty liver disease | University of Michigan | LC-MS |
| ST000664 | AN001015 | Nutritional Psychiatric Illness Studies | Blood | Human | Bipolar I Disorder | University of Michigan | LC-MS |
| ST000662 | AN001011 | Lipidomics of hormone-sensitive lipase variants | Adipose tissue | Human | University of Michigan | LC-MS | |
| ST000661 | AN001009 | CHOICE clinical weight loss study | Blood | Human | Obesity | University of Michigan | LC-MS |
| ST000661 | AN001009 | CHOICE clinical weight loss study | Blood | Rat | Obesity | University of Michigan | LC-MS |
| ST000005 | AN000012 | Timecourse on RAW 264.7 cells treated with Kdo2-Lipid A and compactin | Macrophages | Mouse | LIPID MAPS | GC-MS/LC-MS |
